Andriyoko, Parwati, Tjandrawati, Lismayanti. 2011. Penentuan serotipe virus dengue dan gambaran manifestasi klinis serta hematologi rutin pada infeksi virus dengue dengue virus. MKB. 44(4):253–260.
Back & Lundkvist. 2013. Dengue viruses an overview. Infection Ecology and Epidemiology. 1(3):1–21.
Baratawidjaja & Rengganis. 2004. Imunologi Dasar. Jakarta: Fakultas Kedokteran Universitas Indonesia.
Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow A, Moyes C,et al. 2013. The global distribution and burden of dengue. Nature. 496(7446):504–507.
Candra A. 2010. Demam berdarah dengue: epidemiologi, patogenesis, dan faktor
risiko penularan. Aspirator. 2(2):110–119.
Carabali M, Hernandez LM, Libia MJ, Arauz LA, Maria J V, Ridde, et al. 2015. Why are people with dengue dying? A scoping review of determinants for dengue mortality. BMC Infectious Diseases. 15(301):1–14.
CDC. 2016. Dengue and the Aedes aegypti mosquito. Puerto Rico: Centers for Disease Control.
Dharma R, Rezeki S, Priatni. 2006. Disfungsi endotel pada demam berdarah dengue. Makara. 10(1):17–23.
Dinkes. 2013. Profil Kesehatan Provinsi Lampung Tahun 2012. Lampung: Dinas Kesehatan Provinsi Lampung.
49
Elmy S, BNP Arhana, IKG Suandi. 2009. Obesitas sebagai faktor risiko sindrom syok dengue. Sari Pediatri. 11(4):238–243.
Fitriastri N, Nilapsari R, Kusmiati M. 2015. Hubungan trombositopenia dengan manifestasi klinis Perdarahan pada pasien demam berdarah dengue anak. Prosiding Pendidikan Dokter. 2(2):10–16.
Guilarde AO, Turchi MD, Sigueira JB, Feres VC, Rocha B, Levi, et al. 2008. Dengue and dengue hemorrhagic fever among adults:clinical outcomes related to viremia, serotypes, and antibody response. The Journal of Infectious Disease. 50(197):817-824
Guzman MG, Alvarez M, Halstead SB. 2013. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Archives of Virology. 1587(7):1445–1459.
Halstead SB. 2012. Controversies in dengue pathogenesis. Paediatric and International Health. 32(S1):5–9.
Hammond SN, Balmaseda A, Pérez L, Tellez Y, Saborío S, Mercado JS, Videa E et al. 2005. Differences in dengue severity in infants, children, and adults in a-3 year hospital-based study in nicaragua. AMJ Trop Med. 73(6):1063– 1070.
Hanafusa S, Chanyasanha C, Sujirarat D, Khuankhunsathid I, Yaguchi A, Suzuki T et al. 2008. Clinical features and differences between child and adult dengue infection in Rayong Province, Shouth Thailand. Shouthest Asian J Trop Med Public Health. 39(2):252-259.
Kemenkes. 2013. Situasi Demam Berdarah Dengue di Indonesia. Lampung: Pusat Data dan Informasi Kesehatan Kementerian Kesehatan RI.
Kittigul L, Pitakarnjanakul P, Sujirarat D. 2007. The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection. Journal of Clinical Virology. 39(2):76-81.
Livina, Rotty, Panda. 2012. Hubungan trombositopenia dan hematokrit dengan manifestasi perdarahan pada penderita demam dengue dan demam berdarah
50
dengue. Manado: Fakultas Kedokteran Sam Ratulangi.
Mariko R, Hadinegoro SR, Satari HI. 2014. Faktor prognosis terjadinya perdarahan gastrointestinal dengan demam berdarah dengue pada dua dumah sakit rujukan. Sari Pediatri. 15(6):361–368.
Modhiran N, Watterson D, Muller DA, Panetta A, Sester D, Liu L, et al. 2015. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Viral Toxin. 7(304):1-12.
Namvongsa V, Sirivichayakul C, Songsithichok S, Chanthavanich, Chokejindachai, Sitcharungsi R. 2013. Differences in clinical features between children and adults with dengue hemorrhagic fever/dengue shock syndrome. The Southeast Asian Journal of Tropical Medicine and Public Health. 44(5):772–779.
Orsi FA, Angerami RN, Mazetto BM, Quaino SKP, Santiago-bassora, Castro. 2013. Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case–control study comparing dengue fever patients with and without bleeding manifestations. BMC Infectious Disease. 13(350):1–10.
Pang J, Salim A, Lee V, Hibberd ML, Chia KS, Leo et al. 2012. Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: A case control study. PLoS Negl
Trop Dis. 6(5):1-8.
Rena R, Utama S, Parwati. 2009. Kelainan hematologi pada demam berdarah dengue. J Peny Dalam. 10(3):219–225.
Rowe EK, Leo YS, Wong JG, Thein T, Gan VC, Lee LK,et al., 2014. Challenges in dengue fever in the elderly: Atypical presentation and risk of severe dengue and hospita-acquired infection. PLoS Negl Trop Dis. 8(4):1-6.
Sellahewa KH. 2012. Pathogenesis of dengue haemorrhagic fever and its impact on case management. Hindawi. 20(13):1-6.
Setiabudi D, Setiabudiawan, Parwati, Garnaet. 2013. Perbedaan kadar platelet activating factor plasma antara penderita demam berdarah dengue dan
51
demam dengue the difference of platelet activating factor plasma level between dengue hemorrhagic fever and dengue fever patients. MKB. 45(4):251–56.
Setiati TE, Retnaningsih A, Supriatna M, Soemantri A. 2005. Vascular leakage score as the early predictor of shock. Jurnal Kedokteran Brawijaya. 21(1):16-21.
Sharma SK, Seth T, Mishra P, Gupta N, Agrawal N, Broor S. 2011. Clinical profile of dengue infection in patients with hematological diseases. Mediterranean Journal of Hematology and Infectious Disease. 3(2035):1-4.
de Souza LJ, Bastos P, Carvalho, Assed, Barbosa T, Mariana, et al. 2013. Comparison of clinical and laboratory characteristics between children and adults with dengue. Brazilian Journal of Infectious Diseases. 17(1):27–31.
Sukohar A. 2014. Demam Berdarah Dengue (DBD) Fakultas Kedokteran Universitas Lampung. Medula Unila. 2(2): 1-15.
Tantawichien T. 2012. Dengue fever and dengue haemorrhagic fever in adolescents and adults Paediatric and International Child Health. 32(S1):22-27.
Taufik A, Yudhanto D, Wajdi F, Rohadi. 2007. Peranan kadar hematokrit, jumlah trombosit, dan serologi IgG-IgM antiDHF dalam memprediksi terjadinya syok pada pasien demam berdarah dengue (DBD) di Rumah Sakit Islam Siti Hajar Mataram. J Peny Dalam. 8(2):105–111.
The TD, Thu T, Minh T, Van DN, Tinh NT, Vinh HT, et al., 2012. Clinical features of dengue in a large Vietnamese cohort: intrinsically lower platelet
counts and greater risk for bleeding in adults than children. PLoS Negl Trop Dis. 6(6):1-11.
Vernon J, Lye CB, Sun Y, Fernandez G, Ong A, Leo Y. 2008. Predictive value of simple clinical and laboratory variables for dengue hemorrhagic fever in adults. Journal of Clinical Virology. 42(1):34–39.
52
Wang C, Liu S, Liao S, Lee I, Liu J, Lin A,et al. 2007. Acute Respiratory Failure in Adult Patients with Dengue Virus Infection. Amj Trop Med. 77(1):151– 158.
WHO. 2009. Dengue: Guidelines For Diagnosis, Treatment, Prevention, and Control. Geneva: WHO.
WHO. 2012. Handbook For Clinical Management of Dengue. Geneva: WHO.
World Health Organization. 2011. Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Haemorrhagic Fever. Geneva: WHO.
Wichmann O, Hongsiriwon S, Bowonwatanuwong C, Chureeratana, Chotivanich K. 2004. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi , Thailand. Tropical Medicine and International Health. 9(9):1022–1029.
Yacoub S, Mongkolsapaya J, Screaton G. 2016. Recent advances in understanding dengue. F1000 Faculty Rev. 5(78): 1–10.